Inventor · disambiguated record
Qun Kevin Fang
Also filed as: FANG QUN · FANG QUN K · FANG QUN KEVIN
37 granted patents·15 pending applications·672 citations·filing 1997–2023
98Inventor score
Files withSEPRACOR INC30SUNOVION PHARMACEUTICALS INC10CHYTIL MILAN5Chengdu kanghong pharmaceutical co ltd1FANG QUN KEVIN1
Top patents by PatentIndex Score
52 records- 0198US7423179B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2006·Granted Sep 9, 2008·12 cites·6 claims
- 0298US6342496B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 29, 2002·217 cites·19 claims
- 0396US7790772B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2009·Granted Sep 7, 2010·15 cites·6 claims
- 0496US7189715B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2003·Granted Mar 13, 2007·40 cites·16 claims
- 0596US7087785B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2003·Granted Aug 8, 2006·28 cites·56 claims
- 0694US8063032B2Histamine H3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2010·Granted Nov 22, 2011·53 cites·58 claims
- 0794US7456173B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2006·Granted Nov 25, 2008·11 cites·6 claims
- 0894US7105699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2005·Granted Sep 12, 2006·18 cites·10 claims
- 0994US6476078B2Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunctionSEPRACOR INC·Filed 2001·Granted Nov 5, 2002·43 cites·12 claims
- 1094US6337328B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 8, 2002·59 cites·94 claims
- 1193US7589237B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2008·Granted Sep 15, 2009·14 cites·8 claims
- 1293US7579370B2Fused heterocyclesSEPRACOR INC·Filed 2007·Granted Aug 25, 2009·25 cites·15 claims
- 1386US9072699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·6 claims
- 1485US8134029B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineJERUSSI Thomas·Filed 2010·Granted Mar 13, 2012·7 cites·18 claims
- 1584US7902252B2Inhibitors of D-amino acid oxidaseSEPRACOR INC·Filed 2009·Granted Mar 8, 2011·4 cites·12 claims
- 1684US6780891B2Tramadol analogs and uses thereofSEPRACOR INC·Filed 2002·Granted Aug 24, 2004·20 cites·61 claims
- 1783US8344030B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Jan 1, 2013·3 cites·6 claims
- 1882US10702486B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Jul 7, 2020·0 cites·6 claims
- 1979US6974837B2Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitorsSEPRACOR INC·Filed 2002·Granted Dec 13, 2005·7 cites·15 claims
- 2079US6538034B2Methods of treating or preventing weight gain, obesity, and related disordersFiled 2001·Granted Mar 25, 2003·9 cites·9 claims
- 2177US6331571B1Methods of treating and preventing attention deficit disordersSEPRACOR INC·Filed 1999·Granted Dec 18, 2001·29 cites·4 claims
- 2277US2021046021A1TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINESUNOVION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2376US6710087B2Methods of treating or preventing neuropathic pain using sibutramine metabolitesSEPRACOR INC·Filed 2002·Granted Mar 23, 2004·7 cites·3 claims
- 2476US6399826B1Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating painSEPRACOR INC·Filed 2000·Granted Jun 4, 2002·7 cites·5 claims
- 2576US5925761ASynthesis of terfenadine and derivativesSEPRACOR INC·Filed 1997·Granted Jul 20, 1999·18 cites·12 claims
- 2674US6339106B1Methods and compositions for the treatment and prevention of sexual dysfunctionSEPRACOR INC·Filed 2000·Granted Jan 15, 2002·7 cites·26 claims
- 2771US7071234B2Methods of treating or preventing erectile dysfunctionSEPRACOR INC·Filed 2003·Granted Jul 4, 2006·3 cites·20 claims
- 2870US10328036B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Jun 25, 2019·0 cites·6 claims
- 2968US9884844B2Heterocyclic compounds and methods of use thereofSUNOVION PHARMACEUTICALS INC·Filed 2013·Granted Feb 6, 2018·1 cites·16 claims
- 3066US9907764B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 3166US8658700B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2012·Granted Feb 25, 2014·0 cites·6 claims
- 3264US6025177AAsymmetric grignard synthesis with cyclic 1,2 aminoalcoholsSEPRACOR INC·Filed 1999·Granted Feb 15, 2000·7 cites·22 claims
- 3364US2010029741A1Fused heterocyclesSEPRACOR INC·Filed 2009·Application pending·0 cites
- 3464US2010022612A1Fused heterocyclesSEPRACOR INC·Filed 2009·Application pending·0 cites
- 3562US9498452B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamineSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·0 cites·6 claims
- 3661US6974838B2Methods of treating or preventing pain using sibutramine metabolitesSEPRACOR INC·Filed 2004·Granted Dec 13, 2005·0 cites·12 claims
- 3759US2006128993A1Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2006·Application pending·0 cites
- 3858US2004067957A1Methods of treating or preventing restless leg syndrome using sibutramine metabolitesFiled 2003·Application pending·0 cites
- 3955US8497278B2Imidazo[1,2-a]pyridine compoundsFANG QUN KEVIN·Filed 2009·Granted Jul 30, 2013·0 cites·10 claims
- 4052US2025115578A1Aromatic fused ring nav1.8 inhibitor, and use thereofChengdu kanghong pharmaceutical co ltd·Filed 2023·Application pending·0 cites
- 4151US2013289013A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDSSUNOVION PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4250US2008058395A1Fused heterocyclic inhibitors of D-amino acid oxidaseSEPRACOR INC·Filed 2007·Application pending·0 cites
- 4348US2009099248A1Inhibitors of d-amino acid oxidaseSEPRACOR INC·Filed 2008·Application pending·0 cites
- 4447US6147217ASynthesis of terfenadine and derivativesSEPRACOR INC·Filed 1999·Granted Nov 14, 2000·3 cites·8 claims
- 4547US2002052340A1Bupropion metabolites and methods of their synthesis and useFiled 2001·Application pending·0 cites
- 4646US8404670B2Histamine H3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2011·Granted Mar 26, 2013·0 cites·4 claims
- 4746US2004087661A1Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamineSEPRACOR INC·Filed 2003·Application pending·0 cites
- 4842US2011065694A1Histamine H3 Inverse Agonists and Antagonists and Methods of Use ThereofCHYTIL MILAN·Filed 2010·Application pending·0 cites
- 4942US2012172350A1Histamine h3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2010·Application pending·0 cites
- 5039US6013830AAsymmetric grignard synthesis with cyclic 1,2 aminoalcoholsSEPRACOR INC·Filed 1998·Granted Jan 11, 2000·1 cites·11 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →